Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 792-797

  Tappe, Dennis ^a,b,c   Frosch, Matthias ^a,b,c   Sako, Yasuhito ^a,b,c   Itoh, Sonoyo ^a,b,c   Grüner, Beate ^a,b,c   Reuter, Stefan ^a,b,c   Nakao, Minoru ^a,b,c   Ito, Akira ^a,b,c   Kern, Peter ^a,b,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BENZIMIDAZOLE; CRUDE ANTIGEN EXTRACT; RECOMBINANT ANTIGEN; RECOMBINANT EM ANTIGEN; RECOMBINANT EM10 ANTIGEN; RECOMBINANT EM18 ANTIGEN; UNCLASSIFIED DRUG; ANTHELMINTIC AGENT; HELMINTH ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ECHINOCOCCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIVER TUMOR; LUNG ALVEOLUS; MALE; METASTASIS; REMISSION; SEROLOGY; ANIMAL; BLOOD; ECHINOCOCCUS MULTILOCULARIS; GERBIL; IMMUNOLOGY; LIVER HYDATID CYST; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; COHORT STUDIES; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GERBILLINAE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 66149101631     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.792     Document Type: Article

References (28)

1. Ammann RW, Eckert J, 1996. Cestodes. Echinococcus. Gastroenterol Clin North Am 25: 655-689.
2. Reuter S, Buck A, Grebe O, Nussle-Kugele K, Kern P, Manfras BJ, 2003. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 47:3586-3591.
3. Eckert J, Jacquier P, Baumann D, Raeber PA, 1995. Human echi-nococcosis in Switzerland, 1984-1992 [in German]. Schweiz Med Wochenschr 125:1989-1998.
4. Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA, Gabelmann A, Kern P, Kratzer W, 2007. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast-enhanced ultrasound, three-phase helical CT and [(18) F]fluoro-deoxyglucose positron-emission tomography. Abdom Imaging 32: 730-736.
5. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P, 1999. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 29:1157-1163.
6. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, Deplazes P, von Schulthess GK, Muellhaupt B, Ammann RW, Renner EL, 2007. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 35:11-18.
7. Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL; Swiss Echinococcosis Study Group, 2004. Immunosurveil-lance of alveolar echinococcosis by specific humoral and cellu-lar immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001). J Hepatol 41:551-559.
8. Fujimoto Y, Ito A, Ishikawa Y, Inoue M, Suzuki Y, Ohhira M, Ohtake T, Kohgo Y, 2005. Usefulness of recombinant Em 18-ELISA to evaluate efficacy of treatment in patients with alveo-lar echinococcosis. J Gastroenterol 40: 426-431.
9. Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, Delabrousse E, Kratzer W, Bresson-Hadni S, 2006. WHO classification of alveolar echinococcosis: principles and applica-tion. Parasitol Int 55: S283-S287.
10. Frosch PM, Frosch M, Pfister T, Schaad V, Bitter-Suermann D, 1991. Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol 48:121-130.
11. SakoY, Nakao M, Nakaya K, Yamasaki H, Gottstein B, Lightowers MW, Schantz PM, Ito A, 2002. Alveolar echinococcosis: charac-terization of diagnostic antigen Eml8 and serological evalua-tion of recombinant Eml8. J Clin Microbiol 40:2760-2765.
12. Wellinghausen N, Jochle W, Reuter S, Flegel WA, Grunert A, Kern P, 1999. Zinc status in patients with alveolar echinococcosis is related to disease progression. Parasite Immunol 21:237-241.
13. Schantz PM, Wilson JF, Wahlquist SP, Boss LP, Rausch RL, 1983. Serologic tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multiloc-ularis). Am J Prop Med Hyg 32:1381-1386.
14. Wellinghausen N, Kern P, 2001. A new ImmunoCAP assay for detection of Echinococcus multilocularis-specific IgE. Acta Prop 79:123-127.
15. Dreweck CM, Lüder CG, Soboslay PT, Kern P. 1997. Subclass-specific serological reactivity and IgG4-specific antigen recogni-tion in human echinococcosis. Prop Med Int Health 2:779-787.
16. Ito A, Schantz PM, Wilson JF, 1995. Eml8, a new serodiagnostic marker for differentiation of active and inactive cases of alveo-lar hydatid disease. Am J Prop Med Hyg 52:41-44.
17. Ito A, Wen H, Craig PS, Liang M, Nakao M, Horii T, Pang XL. Okamoto M, Itho M, Osawa Y, Wang XG, Liu YH, 1997. Antibody responses against Em18 and Em16 serodiagnostic markers in alveolar and cystic echinococcosis. Jpn J Med Sci Biol 50:19-26.
18. Wen H, Craig PS, Ito A, Vuitton DA, Bresson-Hadni S, Allan JC, Rogan M, Paollilo E, Shambesh M, 1995. Immunoblot evalua-tion of IgG and IgG subclass antibody responses for immunodi-agnosis of human alveolar echinococcosis. Ann Prop Med Parasitol 89:485-495.
19. Gottstein B. Tschudi K, Eckert J, Ammann R, 1989. Em2-ELISA for the follow-up of alveolar echinococcosis after complete sur-gical resection of liver lesions. Trans R Soc Prop Med Hyg 83: 389-393.
20. Gottstein B, Mesarina B, Tanner I, Ammann RW, Wilson JF, Eckert J, Lanier A, 1991. Specific cellular and humoral immune responses in patients with different long-term courses of alveo-lar echinococcosis (infection with Echinococcus multilocularis). Am J Prop Med Hyg 45:734-742.
21. plus-ELISA and Eml8-western blots for follow-up after treatment with albendazole. Trans R Soc Prop Med Hyg 91:476-478.
22. Miguet JP, Bresson-Hadni S, 1989. Alveolar echinococcosis of the liver. J Hepatol 8: 373-379.
23. Sturm D, Menzel J, Gottstein B, Kern P, 1995. Interleukin-5 is the predominant cytokine produced by peripheral blood mono-nuclear cells in alveolar echinococcosis. Infect Immun 63: 1688-1697.
24. Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B, 2003. In vitro culture of Echinococcus multilocu-laris and Echinococcus vogeli metacestodes: studies on the host-parasite interface. Acta Prop 85: 145-155.
25. Rausch RL, Wilson JF, Schantz PM, McMahon BJ, 1987. Spontaneous death of Echinococcus multilocularis: cases diag-nosed serologically (by Em2 ELISA) and clinical significance. Am J Prop Med Hyg 36: 576-585.
26. Posselt A, 1931. Die pathologische Anatomie der vielkammerigen Blasenwurmgeschwulst (Echinococcus alveolaris) der Leber. Frankf Z Pathol 41: 45-99.
27. Lanier AP, Trujillo DE, Schantz PM, Wilson JF, Gottstein B, McMahon BJ, 1987. Comparison of serologic tests for the diag-nosis and follow-up of alveolar hydatid disease. Am J Prop Med Hyg 37: 609-615.
28. Gottstein B, 1992. Molecular and immunological diagnosis of echi-nococcosis. Clin Microbiol Rev 5:248-261.